These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2254738)

  • 21. [Clinical studies with a new piperidyl-phenothiazine derivative (A 124)].
    Berzewski H; Hippius H; Petri H; Schiffter R
    Arzneimittelforschung; 1970 Jul; 20(7):949-52. PubMed ID: 5536067
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug efficacy and diagnostic specificity in manic depressive illness and schizophrenia.
    Hekimian LJ; Gershon S; Hardesty AS; Burdock EI
    Dis Nerv Syst; 1969 Nov; 30(11):747-51. PubMed ID: 5359047
    [No Abstract]   [Full Text] [Related]  

  • 23. Lithium carbonate in therapy.
    Blinder MG
    Curr Psychiatr Ther; 1970; 10():100-4. PubMed ID: 5528320
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of cerebral complications during treatment with taxilan].
    Grzejdziak W
    Pol Tyg Lek; 1966 Dec; 21(52):2016-7. PubMed ID: 5976282
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 29. Triavil and Etrafon.
    Med Lett Drugs Ther; 1966 Feb; 8(4):14-6. PubMed ID: 5325159
    [No Abstract]   [Full Text] [Related]  

  • 30. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 31. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of acupuncture treatment for a patient with severe axial dystonia appearing during treatment for schizophrenia].
    Tani M; Suzuki T; Takada A; Yagyu T; Kinoshita T
    Seishin Shinkeigaku Zasshi; 2005; 107(8):802-10. PubMed ID: 16259404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proketazine in the treatment of psychotic syndromes].
    Klosińska B; Wierzbicki T
    Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274
    [No Abstract]   [Full Text] [Related]  

  • 35. Acquired aplastic anemia secondary to perphenazine.
    Oyewumi LK
    Can J Clin Pharmacol; 1999; 6(3):169-71. PubMed ID: 10495369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observations on the body experience and motor behavior of schizophrenics during neuroleptic therapy].
    Vella G; Ciani N
    Osp Psichiatr; 1965; 33(4):481-90. PubMed ID: 4381125
    [No Abstract]   [Full Text] [Related]  

  • 37. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment.
    Matsuki A; Oyama T; Izai S; Zsigmond EK
    Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242
    [No Abstract]   [Full Text] [Related]  

  • 40. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.